Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Cash from Operations (2020 - 2025)

LifeStance Health (LFST) has disclosed Cash from Operations for 6 consecutive years, with 57560000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 7.63% to 57560000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 146151000.0, a 36.26% increase, with the full-year FY2025 number at 146151000.0, up 36.26% from a year prior.
  • Cash from Operations was 57560000.0 for Q4 2025 at LifeStance Health, up from 27287000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 64396000.0 in Q2 2025 to a low of 25355000.0 in Q3 2023.
  • A 5-year average of 18325555.56 and a median of 13352000.0 in 2021 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: crashed 542.5% in 2023, then skyrocketed 10252.07% in 2024.
  • LifeStance Health's Cash from Operations stood at 30635000.0 in 2021, then grew by 17.24% to 35918000.0 in 2022, then crashed by 53.24% to 16795000.0 in 2023, then soared by 271.04% to 62316000.0 in 2024, then dropped by 7.63% to 57560000.0 in 2025.
  • Per Business Quant, the three most recent readings for LFST's Cash from Operations are 57560000.0 (Q4 2025), 27287000.0 (Q3 2025), and 64396000.0 (Q2 2025).